← Open Payments lookup

KATELYN SCAGNELLI: Open Payments

NPI 1760634943 · CHELMSFORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$974 in 15 payments from 8 companies in 2025. Trend: 2023 $303 · 2024 $503 · 2025 $974

Food & beverage: $780Education: $194
CompanyPaymentsAmount
Janssen Biotech, Inc.7$279
Astellas Pharma US Inc2$194
JAZZ PHARMACEUTICALS INC.1$137
Kite Pharma, Inc.1$129
ABBVIE INC.1$98
E.R. Squibb & Sons, L.L.C.1$95
Novartis Pharmaceuticals Corporation1$22
Takeda Pharmaceuticals U.S.A., Inc.1$21

Products named: RYBREVANT, ZIIHERA, EMRELIS, REBLOZYL, CARVYKTI, TECVAYLI, KISQALI, NINLARO.

Industry payments across MA — which companies pay providers there.